Brief: Nextcure Presents Preclinical Data On A Novel Therapeutic Candidate Targeting Vstm-1
18/01/2024 22:19
Jan 18 (Reuters) - NextCure Inc NXTC.O :
* NEXTCURE PRESENTS PRECLINICAL DATA ON A NOVEL THERAPEUTIC
CANDIDATE TARGETING VSTM-1 FOR THE TREATMENT OF PROGRESSIVE
INFLAMMATORY AIRWAY DISORDERS
Source text for Eikon: ID:nGNX1df8kp
Further company coverage: NXTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NextCure
See all newsBrief: Xcellon Biologics Co Acquires Gmp Manufacturing Facility From Nextcure
NextCure Inc reports results for the quarter ended June 30 - Earnings Summary
NextCure Q2 net loss narrows on lower expenses
Brief: NextCure Q2 Net Income USD -14.892 Million
NextCure Inc expected to post a loss of $1.93 a share - Earnings Preview